轴性脊柱炎
医学
强直性脊柱炎
重症监护医学
免疫学
骶髂关节炎
作者
Éric Toussirot,Renaud Felten
标识
DOI:10.1080/14712598.2024.2394472
摘要
The therapeutic armamentarium for spondyloarthritis has expanded considerably in recent years, and there is growing evidence to support the increasing use of IL-17 inhibitors (IL-17i) in axial spondyloarthritis (axSpA).
科研通智能强力驱动
Strongly Powered by AbleSci AI